Enliven Therapeutics shares owned by IMC-Chicago
Quarter-by-quarter ownership of Enliven Therapeutics shares owned by IMC-Chicago
from 13F filings
Historical chart of IMC-Chicago investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enliven Therapeutics by IMC-Chicago
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-09-30 | $243k | 5.3k | 45.84 |
Top funds holding Enliven Therapeutics
View all funds holding Enliven Therapeutics